key: cord-0861502-7imunt2g
authors: Clara, Bourgon; Audrey, St Albin; Ophélie, Ando-Grard; Bruno, Da Costa; Roxane, Domain; Brice, Korkmaz; Bernard, Klonjkowski; Sophie, Le Poder; Nicolas, Meunier
title: Neutrophils initiate the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters
date: 2022-03-15
journal: bioRxiv
DOI: 10.1101/2022.03.15.484439
sha: ebb8963fbcad465f68e0d61ca2ac18ee76d0b94c
doc_id: 861502
cord_uid: 7imunt2g

The loss of smell related to SARS-CoV-2 infection is one of the most prevalent symptoms of COVID-19. It is now clear that this symptom is related to the massive infection by SARS-CoV-2 of the olfactory epithelium leading to its desquamation. However, the molecular mechanism behind the destabilization of the olfactory epithelium is less clear. Using golden Syrian hamster, we show here that while apoptosis remains at a low level in damaged infected epithelium, the latter is invaded by innate immunity cells. By depleting the neutrophil population or blocking the activity of neutrophil elastase-like proteinases, we reduced the damage induced by the SARS-CoV-2 infection. Surprisingly, the impairment of neutrophil activity led to a decrease of SARS-CoV-2 infection levels in the nasal cavity. Our results indicate a counterproductive role of neutrophils leading to the release of infected cells in the lumen of the nasal cavity and thereby enhanced spreading of the virus.

Loss of smell (anosmia) is a major symptom of COVID-19 pandemic. With omicron's increased 25 transmission, hundreds of thousands of people per day still get infected worldwide. Despite omicron's 26 reduced anosmia prevalence (UK Health Security Agency Technical Briefing Jan 14, 2022), loss of smell 27 will likely affect millions more (Vaira et al., 2021; von Bartheld et al., 2020) and 10% of anosmic patients 28 might not recover their sense of smell 6 months after the disease onset (3, 4). The full olfactory 29 recovery could even take up to one year and some patients may never recover their sense of smell (5). 30

A recent study estimates that in the US about 720,000 people actually suffer from chronic olfactory 31 disorder related to COVID-19 (6). The loss of smell negatively impacts life quality by disrupting feeding 32 behavior potentially leading to malnutrition; and by exposing to food poisoning and to inhalation of 33 dangerous chemicals (7). In severe and persistent cases, anosmic patients could possibly suffer from 34 chronic depression (8). It is thus crucial to understand the cellular basis of anosmia. 35

Olfaction starts in the olfactory epithelium (OE) which contains olfactory sensory neurons (OSNs) 36 surrounded by supporting cells called sustentacular cells (SCs). Both cell types are regenerated 37 regularly due to multipotent basal cells (9). Among these cells, only SCs express significantly ACE2 and 38 TRPMSS2 required for SARS-CoV-2 cellular entrance (10-12). In a previous study, we observed in the 39 golden Syrian hamster model that SARS-CoV-2 infects massively the sustentacular cells in the OE 40 leading to its desquamation and olfactory neurons loss (Bryche et al., 2020) . Although very rarely OSNs 41 may be infected by SARS-CoV-2 (15), a recent study in humans concludes that anosmia arises primarily 42 from infection of sustentacular cells of the OE followed by the disruption of OE integrity without OSN 43 infection (Khan et al., 2021b) . 44

Previous studies in rodents have concluded that more than 90% of the OE needs to be destroyed to 45 impair olfactory-mediated food-finding behaviour (16). This suggests that a large area of the OE has to 46 become dysfunctional to experience anosmia in COVID-19. How does SARS-CoV-2 achieve such an 47 unprecedented success in dismantling the sense of smell, compared with previous coronavirus and 48 influenza pandemics? Several studies reported that most cells of the infected OE including OSNs 49 undergo apoptosis (17-20) leading to desquamation. A similar phenomenon has been reported during 50 influenza infection (21) and has been considered for SARS-CoV-2 as a defence mechanism to limit a 51 potential invasion of the central nervous system by pathogens using the olfactory route (22). 52

Alternatively, innate immune cells could trigger directly the desquamation of the OE through 53 inflammation as observed in the lung (23). Indeed, innate immune cells invade massively the SARS-54

CoV-2 infected OE (13). Iba1 is a marker of microglia/macrophages (24) which are the most studied 55 innate immunity cells in the nasal cavity (21). Iba1 + microglial cells ensure viral clearance by 56 (1/500 ; goat polyclonal ; 544-10001, Wako). Fluorescence staining was performed using goat anti-125 mouse-A555; goat anti-rabbit-A488 and donkey anti-goat-A546 (1/800; Molecular Probes A21422; 126 A11056; A11008 respectively; Invitrogen; Cergy-Pontoise; France). 127

Images were taken at x100 magnification using a 1X71 Olympus microscope equipped with an Orca ER 128

Hamamatsu cooled CCD camera (Hamamatsu Photonics France; Massy; France). Whole section images 129 were taken at x50 magnification using a Leica MZ10F Fluorescent binocular microscope. 130

To assess olfactory epithelium damage, we used a global score from 1 to 9 based on the integrity of 131 the OE. To evaluate the correlation of apoptosis and innate immune cell presence with damage, OE 132 areas were divided in two groups: undamaged areas (damage score equal to 1 or 2) and damaged areas 133 (damage score between 5 and 9). Apoptosis level, infiltration of immune cells in the OE and its 134 underlying lamina propria were quantified as the percentage of the area positive for C3C (cleaved 135 caspase 3); Iba1 (macrophages/microglia), CD68 (activated bone-marrow-derived macrophages) and 136 MPO (neutrophils). For each animal, the percentage of stained OE was averaged over 4 distinct areas 137

in the beginning of olfactory turbinates at 1 dpi and in the medial part of the nasal cavity containing 138

Steno's gland and NALT at 2 dpi. 139

In cyclophosphamide and in IcatCXPZ-01 experiments, we examined two independent sections of nasal 140 turbinates (separated by 500 µm) in the middle of the nasal cavity containing NALT and Steno's gland. 141

For each section, we set a global score from 1 to 9 for neutrophil infiltration based on the overall 142 presence of MPO signal in nasal mucosa and in nasal cavity lumen. For each section, we also measured 143 the total infected area of the OE, the area of desquamated cells in the lumen (based on Hoechst nuclear 144 staining) and the percentage of infected desquamated cells in the lumen (based on N protein 145 immunostaining). 146

All quantifications were made with ImageJ (Rasband, W.S., ImageJ, U.S. National Institutes of Health, 147

Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997-2012) to threshold specific staining. 148

Total RNA was extracted from frozen nasal turbinates using the Trizol-chloroforme method as 150 described previously (39). Oligo-dT first strand cDNA synthesis was performed from 5 µg total RNA 151 with iScript Advance cDNA Synthesis Kit for RT-qPCR (Bio-Rad; #1725038) following manufacturer's 152 recommendations. qPCR was carried out using 125 ng of cDNA added to a 15 µL reaction mix. This 153 reaction mix contained 10 µL iTaq Universal Sybr Green SuperMix (BioRad; #1725124), and primers at 154 500 nM (sequences in Supp. Table 1 ). The reaction was performed with a thermocycler (Mastercycler 155 ep Realplex, Eppendorf). Fluorescence during qPCR reaction was monitored and measured by Realplex 156 Eppendorf software. A dissociation curve was plotted at the end of the fourty amplification cycles of 157 the qPCR to check the ability of theses primers to amplify a single and specific PCR product. 158

Quantification of initial specific RNA concentration was done using the ΔΔCt method. Standard controls 159 of specificity and efficiency of the qPCR were performed. The mRNA expression of each gene was 160 normalized with the expression level of G3PDH. A correction factor was applied to each primer pair 161 according to their efficiency (40). 162 

We previously observed that as soon as two days following nasal instillation of SARS-CoV-2 in Syrian 186 gold hamsters, the sustentacular cells of the olfactory epithelium were massively infected along with 187 strong cellular loss and cellular debris filling the lumen of the nasal cavity (13). In order to understand 188 the events leading to this desquamation, we chose to focus on the early stages of infection at 1 and 2 189 dpi. To evaluate the importance of apoptosis in the damage of the olfactory epithelium following CoV-2 infection, we measured the level of cleaved caspase 3 signal in uninfected animals, and in 191 infected zones of the OE that were either intact or damaged (Fig. 1) . Basal level of apoptosis occurring 192 in the OE was not increased in either zone at 1 or 2 dpi (Fig. 1D) . However, we observed a strong 193 cleaved caspase 3 signal co-localizing partly with desquamated cell in the lumen of the nasal cavity. 194

The cleaved caspase 3 signal in the lumen of the nasal cavity was increased 5-and 14-fold compared 195

to the OE at 1 and 2 dpi respectively, which was statistically significant at 2 dpi (Mann Whitney, 196 p=0.0286) and nearly significant at 1 dpi (p=0.0525). 197

Cleaved caspase 3 signal in the olfactory epithelium normalized to control (log 10, Mean ± SEM, n=4, *p<0.01 (Mann-Whitney test)).

Since apoptosis does not significantly occur in the OE during the initial phase of infection, the 199 desquamation of the infected OE may be related to immune cell infiltration (Bryche et are well characterized in the OE (21). Iba1 + cells are described as microglia/macrophages but CD68 is 203 more classically used as a marker of monocytes and macrophages (42). Concerning neutrophils, the 204 presence of neutrophil cytosol factor 2 (ncf2; (43)) and myeloperoxydase (MPO) have been used 205 successfully to characterize these cells in hamsters (44). 206

We first evaluated at 1 dpi and 2 dpi by qPCR the expression of Iba1, CD68 and Ncf2 along with classical 207 inflammatory markers (TNFα and IL6) and the presence of the virus (Supp. Fig 1) . At 1 dpi, SARS 208 Nucleocapsid protein (SARS N) was already abundantly expressed in the OE at a similar level as at 2 209 dpi, and TNFα and IL6 transcripts increased gradually (Mann-Whitney, p<0.05). Iba1 and CD68 210 expression related to macrophage presence in the OE did not rise significantly at 1 dpi compared to 211 control (Mann-Whitney, p=0.164 and 0.128 respectively) but did at 2 dpi (Mann-Whitney, p<0.05). 212

Concerning neutrophils, ncf2 expression was strongly enhanced at 1 dpi and was still increasing at 2 213 dpi (Mann-Whitney, p<0.05). These results suggest that neutrophils are already recruited at 1 dpi and 214 that their recruitment continues at 2 dpi along with the arrival of Iba1 + and CD68 + cells. 215

We next focused on immunostaining to characterize the presence of Iba1 + , CD68 + and MPO + cells. In 216 the OE of an uninfected hamster, Iba1 + cells were already present and mainly localized in the lamina 217 propria while CD68 signal was absent ( Fig. 2A) indicating that Iba1 + cells do not express the classical 218 CD68 marker of macrophages. This was confirmed in the infected areas of the OE where we observed 219 a very different presence of Iba1 + and CD68 + cells. Iba1 + cells were massively present as soon as 1 dpi 220 in the damaged parts of the infected OE as well as in the desquamated cells in the lumen of the nasal 221 cavity. CD68 + cells were less abundant in the damaged part of the OE and mainly present in the 222 desquamated cells filling the lumen of the nasal cavity (Fig. 2B) . A double staining against Iba1 and 223 CD68 of the desquamated cells in the lumen of the nasal cavity did not reveal any overlap of the two 224 markers (Supp. Fig. 2) , showing that Iba1 + cells do not express CD68 once they are located among the 225 its correlation with damage, we focused on 3 zones similarly as for apoptosis quantification: 235 1/ uninfected, infected 2/ without or 3/ with damage at 1 and 2 dpi. The infiltration level of Iba1 + cells in 236 the OE was increased in the damaged infected zone but not in the undamaged one (Fig. 3) . This 237 difference was statistically significant at 2 dpi (Mann-Whitney, p= 0.0286) and nearly significant at 1 238 dpi (p= 0.0525). The infiltration of these cells was similarly increased in the lamina propria underneath 239 the previous OE zones with a significant difference at 2 dpi (p= 0.0286). We observed a significant 240 correlation between the damage of the OE and their presence in both the OE and the underlying lamina 241 propria (Spearman test, p = 0.0098 and 0.0006 respectively). 242 We similarly examined whether the presence of CD68 + macrophages and MPO + neutrophils in the OE 243 was associated with the damage of the OE after SARS-CoV-2 infection. Both CD68 and MPO signals 244 were increased in the damaged infected zone but not in the undamaged one (Fig. 4) . This difference 245 was statistically significant in the infected damaged zones at 1 and 2 dpi for both markers compared 246 to control and infected undamaged zones of the OE and lamina propria (Mann-Whitney, p< 0.05). We 247 observed a significant correlation between the damage of the OE and their presence the presence of 248 both CD68 + and MPO + cells the OE and the lamina propria (Spearman test, p <0.001). 249 were also decreased by ~3-fold, and monocytes by ~5-fold (Supp Fig. 3A) . Since cyclophosphamide can 258 impact basal cell proliferation and thus OE structure, we examined its effect in uninfected animals and 259 did not observe any evident damage on the OE structure (Supp Fig. 3B) . We next examined the impact 260 of this treatment on the expression of genes related to the innate immune system in the nasal 261 turbinates during SARS-CoV-2 infection. At 1 dpi, the expression of Iba1 and CD68 reflecting the 262 population of microglia and monocytes/macrophages respectively was not statistically different 263 between vehicle and cyclophosphamide treated animals but a decrease of Ncf2 expression reflecting 264 a reduced presence of neutrophils almost reached significance (Mann Whitney; p=0.0571; Fig. 6A) . We 265 observed a tendency of TNFα and IL6 expression reduction which did not reach significance either 266 (p=0.1143). Despite the overall tendency of a decrease of innate immune system response at 1 dpi, 267 the level of SARS-CoV-2 infection reflected by N protein expression was decreased and the difference 268 almost reached significance (p=0.0571). At 2 dpi, the expression of all genes related to innate immune 269 cell presence as well as TNFα were decreased (p<0.05). We could not make definitive conclusions 270 about IL6 and SARS-CoV-2 N protein expression because it was very variable in cyclophosphamide 271 treated animals. We examined histologically the damage and the level of infection in the OE (Fig. 5 B,  272   C) . MPO signal was significantly decreased at 1 dpi in the OE of cyclophosphamide treated animals 273 compared to control (p<0.05) but was too variable at 2 dpi to reach significance (Fig. 5 Da) . The damage 274 in the OE was significantly decreased at 1 and 2 dpi (p<0.01 and p<0.05 respectively) (Fig. 5 Db) . The 275 reduction tendency of the virus presence measured by the N protein expression was confirmed by 276 immunostaining in the OE at 1 dpi only (p<0.05; Fig. 6 Dc). We hypothesize that this reduction could be 277 linked to less infected desquamated cells released into the lumen of the nasal cavity following the 278 damage induced by the neutrophils. We thus quantified the area of desquamated cells in the lumen 279 which was significantly decreased at 1 dpi and almost reached significance at 2 dpi (Fig. 5 Dd; p<0.001 280 and p=0.0905 respectively). In the desquamated cells of the lumen, the percentage of infected cells 281 was significantly diminished at 1 dpi (Fig. 5 De; p<0.001) but not at 2 dpi when infected desquamated 282 cells were in the lumen of the nasal cavity in some treated animals (Supp Fig. 3C ). Since the reduction 283 of SARS-CoV-2 replication in the nasal cavity of immunocompromised animal was unexpected, we 284 verified that a dose 3 times higher than the maximum dose of cyclophosphamide potentially present 285 in the hamsters during infection did not limit the virus replication in vitro (Supp Fig. 4A) . 286 

In order to confirm our results on cyclophosphamide treatment which affects immune cells other than 289 neutrophils, we treated animals with an inhibitor of cathepsin C (IcatCXPZ-01) which is essential for the 290 maturation of elastase-like proteinases of neutrophils. This inhibitor has been used successfully to 291 almost completely eliminate the elastase-like activity of neutrophils in vivo (38). We chose to focus on 292 the histological impact of IcatCXPZ-01 treatment at 1 dpi as it gave the most significant results during 293 cyclophosphamide treatment. The inhibition of elastase-like proteinases of neutrophils gave similar 294 results as cyclophosphamide treatment even though we sometimes observed locally restricted 295 neutrophil infiltration in the OE (Fig. 6 A, B) . Globally the MPO + neutrophil presence in the nasal 296 turbinates and the damage in the infected area of the OE were significantly reduced compared to 297 vehicle treated animals ( Fig. 6C1 ; Mann-Whitney; p<0.01). We also observed significantly less 298 desquamated cells in the lumen of the nasal cavity which were also less infected ( Fig. 6C2 ; Mann-299 Whitney; p<0.01). Since we observed again that the inhibition of neutrophil action limited SARS-CoV-300 2 replication, we verified that a dose 3 times higher than the maximum dose of IcatCXPZ-01 potentially 301 present in the hamsters during infection did not impair the virus replication in vitro (Supp Fig. 4B) . 302 Mann-Whitney test) ).

The anosmia induced by SARS-CoV-2 infection is now clearly linked to the infection of the olfactory 304 epithelium with a main tropism for sustentacular cells (46, 47) . We and others have observed that 305 following this infection, the OE undergoes massive damage leading to cell desquamation and cellular 306 debris filling the lumen of the nasal cavity (13, 19, 20) , but the mechanism of this destruction is less 307 clear. 308

Several studies reported an increase of apoptosis especially in olfactory sensory neurons (18-20) and 309 assumed that it led to the destruction of the OE. Here, we first examined the apoptosis level based on 310 cleaved caspase 3 level in the OE of uninfected animals and infected areas of the OE, either intact or 311 damaged. If apoptosis initiates the desquamation process then it should increase in the damaged areas 312 of the OE. However, we observed a similar level of apoptosis level in all these areas which was 313 consistent with the basal level of apoptosis that we previously measured in adult mice and rats OE (48, 314 49). While the apoptosis in the infected damaged OE was low, we observed an increased level of 315 apoptosis in cells present in the lumen of the nasal cavity. The discrepancy with previous studies may 316 be due to different models as some were performed using transgenic mice expressing hACE2 but it 317 should be noted that these studies did not perform any quantification or misinterpreted some 318 apoptosis staining in the lumen of the nasal cavity as can be observed with TUNEL staining (20) . The 319 induction of apoptosis by loss of cell contact is well described (50), a phenomenon known as anoikis 320 (51). It indicates that desquamated cells are sufficiently preserved to be able to enter apoptosis after 321 the desquamation process is initiated following OE SARS-CoV-2 infection. 322

Since we previously observed that the infected area of the OE is infiltrated by immune cells (13), we 323 next explored whether innate immune cells are involved in this process, especially macrophages and 324 neutrophils known to be involved in damage of epithelial cells during acute inflammation (28, 29). If 325 so, we should systematically observe their presence in the damaged area of the OE. We first 326 characterized the presence of these cells in the infected OE. We observed that CD68, a classical marker 327 of macrophages (42) was expressed in a different population than Iba1 + cells previously described as a 328 microglia/macrophages cellular population (24). Therefore, in the following, we will refer to Iba1 + cells 329 as microglia, and CD68 + cells as macrophages to avoid confusion between these two cells types. 330

Immunostaining revealed that at 1 dpi, some parts of the OE in the most rostral part of the nasal cavity 331 were already significantly damaged. We observed that in these tissues, microglia cells were mainly 332 recruited while macrophages and neutrophils appeared in the zones desquamating toward the lumen 333 of the nasal cavity. We can thus hypothesize that microglia are first infiltrating the SARS-CoV-2 infected 334 OE. This is not consistent with our qPCR results indicating that neutrophils are recruited more 335 abundantly at 1 dpi than microglia and macrophages. However, we observed that contrary to successfully used in hamsters (44). We confirmed that such treatment mainly impacts neutrophils but 348 also reduced to a lesser degree other leucocyte populations. As expected such treatment reduced 349 neutrophil infiltration in infected areas of the OE and we observed that damage of the infected OE was 350 significantly reduced as well. In order to confirm the role of neutrophils in the damage of the OE 351 following SARS-CoV-2 infection, we treated hamsters with an inhibitor of cathepsin C (IcatCXPZ-01) 352 strongly reducing the neutrophil elastase-like proteinases activity. We observed that similar to 353 cyclophosphamide treatment, the damage of the OE was greatly reduced in this context. Surprisingly, 354 the global infiltration of neutrophils was reduced as well, even though we observed that some 355 neutrophils were still present in the most infected area of the OE. Since neutrophils are mainly present 356 among the desquamated cells present in the lumen of the nasal cavity, the reduction in neutrophil 357 infiltration during IcatCXPZ-01 treatment may be linked to a decrease of the OE damage as elastase-like 358 proteinase action increases inflammation (52). It suggests that the damage of the OE initiated by 359 neutrophils may participate in the increasing infiltration of neutrophils leading in fine to massive 360 damage of the infected OE areas. Overall, these results show that neutrophils have a major causative 361 role in the destruction of the OE following SARS-CoV-2 infection by releasing elastase-like proteinases. 362

We observed that at 1 dpi, the level of SARS-CoV-2 infection was reduced in cyclophosphamide and 363

IcatCXPZ-01 treated hamsters. Such a result was unexpected as neutrophils should effectively destroy 364 infected cells and thus their action should reduce infection progression. Since we observed that these 365 treatments did not impair SARS-CoV-2 replication in vitro, we hypothesize that neutrophils may have 366 a counterproductive effect by releasing infected cells into the lumen of the nasal cavity. These infected 367 cells could allow the virus to spread more easily in the nasal cavity due to impairment of mucociliary 368 clearance that has been recently shown to be reduced during SARS-CoV-2 infection (53). Such a 369 hypothesis is consistent with our results showing that cyclophosphamide and IcatCXPZ-01 treatment 370 significantly reduced the amount of infected desquamated cells filling the lumen of the nasal cavity. 371

Such a phenomenon has been observed recently in vitro in respiratory epithelial cell culture where 372 infection is enhanced in the presence of neutrophils. In their preliminary study, SARS-CoV-2 alone did 373 not significantly increase cytokine production but the neutrophil presence did, showing a major role 374 of the neutrophils in the epithelial response to SARS-CoV-2 infection (54). At 2 dpi, the impact of 375 neutropenia on SARS-CoV-2 infection in the nasal cavity was statistically significant through the 376 reduction of OE damage. The neutropenia induced by the cyclophosmamide treatment was only 377 partial, we can thus hypothesize that the remaining neutrophils can be more effectively recruited when 378 infection progresses and thus we could no longer observe a statistically significant decrease of 379 neutrophil infiltration and SARS-CoV-2 infection in the OE. 380

Overall, our results show that the SARS-CoV-2 infection does not directly induce the massive damage 381 of the OE but that neutrophils play a major role by releasing elastase-like proteinase in the infected 382 OE. This probably leads to the destabilisation of the OE structures and the expulsion of cells including 383 non-infected neurons into the lumen of the nasal cavity where they would undergo apoptosis. In the 384 early phase of the infection, such expulsion of infected cells could enhance the virus infection in the 385 nasal cavity (Fig. 7) . We observed damaged areas of the OE as soon as 1 dpi indicating that the innate 386 immune system is extremely efficient in detecting SARS-CoV-2 infected cells to destroy them. The 387 signal triggering this very fast action remains to be explored. The host's immune defence system that 388 may be present to prevent pathogen invasion from the nose to the brain seems beneficial for SARS-389

CoV-2 to achieve a much more extensive infection of the OE than any previous virus, resulting in 390 unprecedented olfactory dysfunction in the COVID-19 pandemic. 391 

Prevalence of Chemosensory Dysfunction in COVID-412 19 Patients: A Systematic Review and Meta-analysis Reveals Significant Ethnic Differences

The Laryngoscope

Six-month psychophysical evaluation of olfactory 420 dysfunction in patients with COVID-19

Prevalence and 6-423 month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients

Clinical Outcomes for Patients With Anosmia 1 Year After COVID-19 Diagnosis

Growing Public Health Concern of COVID-19 Chronic 429

Olfactory Dysfunction

COVID 19-Induced Smell and 432 Taste Impairments: Putative Impact on Physiology

Loss of Olfactory Function-435

Early Indicator for Covid-19, Other Viral Infections and Neurodegenerative Disorders. Frontiers 436 in neurology

438 Stem and progenitor cells of the mammalian olfactory epithelium: Taking poietic license

Expression of the SARS-CoV

Cells of the Olfactory Epithelium: Identification of Cell Types 442 and Trends with Age

Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory 447 system suggests mechanisms underlying COVID-19-associated anosmia

SARS-CoV-2 receptors and entry genes are expressed in the 451 human olfactory neuroepithelium and brain. iScience

Massive transient damage of the olfactory epithelium associated with 455 infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain, behavior, and 456 immunity

The olfactory nerve is not a likely route to 461 brain infection in COVID-19: a critical review of data from humans and animal models

Denervation of the primary olfactory pathway in 464 mice. V. Long-term effect of intranasal ZnSO4 irrigation on behavior, biochemistry and 465 morphology

The Microvillar and Solitary Chemosensory Cells as the Novel Targets of Infection 468 of SARS-CoV-2 in Syrian Golden Hamsters

SARS-CoV-2 471 infection in the mouse olfactory system. Cell discovery

Comparative pathology of the nasal 473 epithelium in K18-hACE2 Tg mice, hACE2 Tg mice, and hamsters infected with SARS-CoV-2

Severe Acute 477 Respiratory Syndrome Coronavirus 2 Infects and Damages the Mature and Immature Olfactory 478 Sensory Neurons of Hamsters

Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus 481 into the brain by undergoing virus-induced apoptosis. The Journal of general virology

Is anosmia the price to pay in an immune-induced scorched-earth policy 484 against COVID-19? Medical hypotheses

The Role of Epithelial Damage in the Pulmonary 486 Immune Response

A Novel Geneiba1in the Major Histocompatibility 488

Complex Class III Region Encoding an EF Hand Protein Expressed in a Monocytic Lineage. 489 Biochemical and Biophysical Research Communications

Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit 494 monocytes through P2Y12-independent mechanisms

Microglia are required for protection 496 against lethal coronavirus encephalitis in mice

498 Chemokine receptors CCR2 and CX3CR1 regulate viral encephalitis-induced hippocampal 499 damage but not seizures

Neutrophil recruitment and function in health and inflammation

Monocytes and 503 macrophages in COVID-19: Friends and foes

Human granulocyte elastase. Further delineation of its role in connective tissue 505 damage

The role of neutrophil elastase in acute lung injury

Neutrophil Extracellular Traps Directly Induce Epithelial and 512 Endothelial Cell Death: A Predominant Role of Histones

Macrophage Cytokines: Involvement in Immunity and 514 Infectious Diseases

Macrophage depletion in the murine olfactory epithelium leads to increased neuronal death 517 and decreased neurogenesis

Macrophage-mediated neuroprotection and neurogenesis in the olfactory epithelium. 520 Physiological genomics

Structure-based design and in vivo anti-arthritic activity 523 evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C. Biochemical 524 pharmacology

Prolonged 528 pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases. 529 Biochemical pharmacology

Respiratory syncytial virus tropism 532 for olfactory sensory neurons in mice

Processing of gene expression data generated 534 by quantitative real-time RT-PCR

Neutrophil-macrophage cooperation and its impact on tissue repair

Molecular cloning of CD68, a human macrophage marker related to 538 lysosomal glycoproteins

Cloning of a 67-kD Neutrophil Oxidase Factor with Similarity to a 541 Noncatalytic Region of p60 c-src

A secondary wave of 543 neutrophil infiltration causes necrosis and ulceration in lesions of experimental American 544 cutaneous leishmaniasis

Innate 546 immune responses and neuroepithelial degeneration and regeneration in the mouse olfactory 547 mucosa induced by intranasal administration of Poly(I:C)

Administration of 551 aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal 552 neuroinvasion

Visualizing 557 in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae 558 but spares the olfactory bulb

IL-17c is 560 involved in olfactory mucosa responses to Poly(I:C) mimicking virus presence. Brain, behavior

Chronic variable stress exposure in male 563 Wistar rats affects the first step of olfactory detection

Apoptosis induced by 565 inhibition of intercellular contact

Anoikis: an emerging hallmark in health and 567 diseases

The Role of Neutrophil Elastase in Chronic Inflammation

Mucociliary Transport Deficiency and Disease 574 Progression in Syrian Hamsters with SARS-CoV-2 Infection

Neutrophil-epithelial interactions augment infectivity and pro-inflammatory 578 responses to SARS-CoV-2 infection